Which hedge funds own SANA? SANA BIOTECHNOLOGY INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
10 of the hedge funds tracked by WhaleCreep disclosed a position in SANA (SANA BIOTECHNOLOGY INC) in their Q2 2026 13F filings, worth $90.1m in total. The largest holder by portfolio weight is RA Capital Management at 0.6% of its book. 2 managers opened a new position this quarter: RA Capital Management, Point72 Asset Management LP. 1 exited: Baillie Gifford.
10tracked managers holding
2opened this quarter
1exited this quarter
Which hedge funds hold SANA? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| RA Capital Management | Q2 2026 | 0.6% | $65.4m | 18,750,000 | – | new |
| Woodline Partners | Q2 2026 | 0.0% | $4.6m | 1,317,932 | 0% | held |
| Marshall Wace | Q2 2026 | 0.0% | $10.2m | 2,931,436 | 341% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $4.3m | 1,231,100 | -15% | reduced |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $2.1m | 595,091 | – | new |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $183.4k | 52,545 | -1% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $2.3m | 653,503 | -59% | reduced |
| Tudor Investment | Q2 2026 | 0.0% | $306.7k | 87,892 | -34% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $562.5k | 161,178 | -72% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $139.9k | 40,090 | 4% | added |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Baillie Gifford | 2.1% | $19.0m |
How has hedge fund ownership of SANA changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 10 | $90.1m |
| Q1 2026 | 9 | $35.8m |
| Q4 2025 | 3 | $39.1m |
| Q3 2025 | 3 | $31.0m |
| Q2 2025 | 4 | $15.4m |
| Q1 2025 | 2 | $9.8m |
| Q4 2024 | 4 | $10.5m |
| Q3 2024 | 3 | $20.1m |
| Q2 2024 | 4 | $64.6m |
| Q1 2024 | 4 | $209.1m |
| Q4 2023 | 4 | $36.8m |
| Q3 2023 | 6 | $48.2m |
| Q2 2023 | 4 | $49.1m |
| Q1 2023 | 5 | $30.7m |
| Q4 2022 | 3 | $46.9m |
| Q3 2022 | 4 | $56.0m |
Counts every tracked manager that disclosed SANA in that quarter's filing, including managers that have since stopped filing.